phenyl acetate has been researched along with Pulmonary Eosinophilia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jawhari, N; Strauss, RA | 1 |
| Kaliterna, DM; Perković, D; Radić, M | 1 |
| Abla, N; Arrighi, JF; Augustine, JK; Burgat-Charvillon, F; Cleva, C; Crosignani, S; Daff, H; Fraboulet, G; Gaudet, M; Hamernig, I; Humbert, Y; Johnson, Z; Jorand-Lebrun, C; Juillard, P; Missotten, M; Prêtre, A; Rivron, D; Schneider, M; Schott, O; Seenisamy, J; Zimmerli, SC | 1 |
| Cai, C; Chen, QL; He, MZ; Sun, BQ; Tang, Y; Zhong, NS; Zhong, SQ | 1 |
| Bubendorf, L; Conen, D; Hauser, T; Leuppi, J; Ronsdorf, A; Tamm, M | 1 |
| Cartier, A; Hargreave, FE; Jayaram, L; Lemière, C; Man, SF; Pizzichini, E; Pizzichini, MM | 1 |
| Ahn, K; Joung, H; Kim, DY; Kim, JH; Kwon, OK; Lee, HK; Lee, J; Lee, MY; Lee, S; Oh, SR; Park, BY | 1 |
| Artés, MJ; Franco, J | 1 |
| Boulet, LP; Efthimiadis, AE; Hargreave, FE; Hendeles, L; Leff, JA; Pizzichini, E; Reiss, TF; Wei, LX; Zhang, J | 1 |
3 trial(s) available for phenyl acetate and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: a pilot study.
Topics: Acetates; Adult; Aged; Bronchitis; Bronchodilator Agents; Budesonide; Chronic Disease; Cough; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Pilot Projects; Pulmonary Eosinophilia; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2012 |
Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Topics: Acetates; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Patient Compliance; Pulmonary Eosinophilia; Quinolines; Sputum; Sulfides; Treatment Outcome | 2005 |
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
Topics: Acetates; Adult; Asthma; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Pulmonary Eosinophilia; Quinolines; Respiratory Function Tests; Respiratory Tract Diseases; Safety; Sputum; Sulfides; Treatment Outcome | 1999 |
6 other study(ies) available for phenyl acetate and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Cyclopropanes; Drug Administration Schedule; Eosinophils; Female; Humans; Injections, Subcutaneous; Interleukin-5; Male; Middle Aged; Prednisone; Pulmonary Eosinophilia; Quinolines; Retrospective Studies; Rhinitis, Allergic; Severity of Illness Index; Sulfides; Surveys and Questionnaires | 2018 |
Churg-Strauss syndrome associated with montelukast therapy.
Topics: Acetates; Adult; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Pulmonary Eosinophilia; Quinolines; Sulfides | 2009 |
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Topics: Acetates; Administration, Oral; Alkynes; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Binding, Competitive; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Cell Shape; Chemotaxis, Leukocyte; Dermatitis, Contact; Eosinophils; Female; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Microsomes, Liver; Ovalbumin; Phenoxyacetates; Protein Binding; Pulmonary Eosinophilia; Radioligand Assay; Rats; Receptors, Immunologic; Receptors, Prostaglandin; Structure-Activity Relationship; Sulfones | 2011 |
Montelukast and Churg-Strauss syndrome.
Topics: Acetates; Asthma; Biopsy, Needle; Churg-Strauss Syndrome; Cyclopropanes; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunohistochemistry; Immunosuppressive Agents; Leukotriene Antagonists; Male; Middle Aged; Pulmonary Eosinophilia; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Sulfides; Switzerland; Treatment Outcome | 2004 |
Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Female; Glucosides; Immunoglobulin E; Interleukin-13; Interleukin-4; Iridoid Glucosides; Iridoids; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Molecular Structure; Mucus; Ovalbumin; Plant Extracts; Pneumonia; Pulmonary Eosinophilia; Quinolines; Sulfides; Veronica | 2006 |
Pulmonary eosinophilia associated with montelukast.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Fever; Humans; Leukotriene Antagonists; Male; Pulmonary Eosinophilia; Quinolines; Respiratory Sounds; Sulfides | 1999 |